Results 141 to 150 of about 7,829,046 (305)

A model for geographical variation in health and total life expectancy [PDF]

open access: yes
This paper develops a joint approach to life and health expectancy based on 2001 UK Census data for limiting long term illness and general health status, and on registered death occurrences in 2001.
Peter Congdon
core  

Physical activity and life expectancy: a life-table analysis

open access: yes
Objective Low physical activity (PA) levels are associated with increased mortality. Improved measurement has resulted in stronger proven associations between PA and mortality, but this has not yet translated to improved estimates of the disease burden ...
Tarp, Jakob   +16 more
core   +1 more source

A role for eIF5A in translational control of stress‐inducible proteins in multiple myeloma cell lines

open access: yesMolecular Oncology, EarlyView.
Loss of eIF5A rewires thapsigargin‐mediated endoplasmic reticulum stress responses in multiple myeloma cells by selective translation of mRNA transcripts, consequently dampening thapsigargin‐induced unfolded protein response (UPR) activation and shifting the balance from induction of apoptosis toward cell survival and proliferation.
Demi Both   +7 more
wiley   +1 more source

Trends in life expectancy and the macroeconomy in Malawi [PDF]

open access: yes
The purpose of this paper was to study trends in life expectancy in Malawi since independence and offer possible explanations regarding its inter-temporal variations.
Matchaya, Greenwell C
core  

The Impact of Changes in Educational Attainment on Life Expectancy in Ireland. WP414. November 2011 [PDF]

open access: yes, 2011
The purpose of this article is to quantify the contribution of the increasing educational attainment of the Irish population to the prospective improvement in life expectancy over the next 50 years.
FitzGerald, John   +2 more
core  

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

The life expectancy gains from pharmaceutical drugs: a critical appraisal of the literature [PDF]

open access: yes
Several studies suggest that, on the basis of life expectancy (LE) regressions, new pharmaceutical drugs are responsible for some of the marked gains in LE observed over the last 50 years. We critically appraise these studies.
Paul Grootendorst   +2 more
core  

Regulation of the lncRNA NEAT1 by p53‐ΔNp63 crosstalk modulates the DNA damage response and therapeutic efficacy in HNSCC

open access: yesMolecular Oncology, EarlyView.
In head and neck squamous cell carcinoma (HNSCC) p53 and p63 exert opposite roles on the transcription regulation of the lncRNA NEAT1. Under basal conditions, p53 levels are low and p63 represses NEAT1 expression. Upon genotoxic stress, p53 is rapidly induced, displacing p63 from the NEAT1 promoter leading to NEAT1 transcriptional activation and ...
Sara De Domenico   +5 more
wiley   +1 more source

Explaining the Cross-National Time Series Variation in Life Expectancy: Income, Women’s Education, Shifts, and What Else? [PDF]

open access: yes
This paper examines the variation across countries and evolution over time of life expectancy. Using historical data going back to the beginning of the 20th century several basic facts about the relationship between national income and life expectancy ...
Lant Pritchett, Martina Viarengo
core  

Quantifying the potential gains in life expectancy from eliminating cardiovascular disease, road traffic injuries, and cancers in Iran

open access: yesBMC Research Notes
Background Life expectancy (LE) serves as a critical health metric for assessing changes in risk factors, health outcomes, and the effectiveness of medical treatments.
Ramin Naserian-Tarhan   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy